Proteomics mapping of cord blood identifies haptoglobin "switch-on" pattern as biomarker of early-onset neonatal sepsis in preterm newborns

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Buhimschi, Catalin S ^a   Bhandari, Vineet ^a,b   Dulay, Antonette T ^a   Nayeri, Unzila A ^a   Abdel Razeq, Sonya S ^a   Pettker, Christian M ^a   Thung, Stephen ^a   Zhao, Guomao ^a   Han, Yiping W ^c   Bizzarro, Matthew ^b   Buhimschi, Irina A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HAPTOGLOBIN; INTERLEUKIN 6;

AMNIONITIS; ARTICLE; BAYES THEOREM; BLOOD SAMPLING; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY LIFE STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL PROTEOMICS; GENE SWITCHING; HUMAN; IMMUNOREACTIVITY; MALE; MASS SPECTROMETRY; NEWBORN; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PEPTIDE MAPPING; PHENOTYPE; PREMATURITY; PRENATAL EXPOSURE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UMBILICAL CORD BLOOD; WESTERN BLOTTING; BLOOD; COHORT ANALYSIS; FETUS BLOOD; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PROBABILITY; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY; SEPSIS;

BAYES THEOREM; BIOLOGICAL MARKERS; BLOTTING, WESTERN; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HAPTOGLOBINS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREMATURE BIRTH; PROBABILITY; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SEPSIS;

EID: 80053899511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026111     Document Type: Article

References (82)

1. Robertson CM, Watt MJ, Yasui Y, (2007) Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 24: 2733-2740.
2. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, et al. (2007) Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 4: e18.
3. Tita AT, Andrews WW, (2010) Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 37: 339-354.
4. Klinger G, Levy I, Sirota L, Boyko V, Lerner-Geva L, et al. (2010) Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 125: e736-740.
5. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, et al. (2011) Early-onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues. Pediatrics 127: 817-826.
6. McCrea HJ, Ment LR, (2008) The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 35: 777-792.
7. Buhimschi CS, Bhandari V, Han YW, Dulay AT, Baumbusch MA, et al. (2009) Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis 22: 235-243.
8. Kolialexi A, Mavrou A, Spyrou G, Tsangaris GT, (2008) Mass spectrometry-based proteomics in reproductive medicine. Mass Spectrom Rev 27: 624-634.
9. Arnon S, Litmanovitz I, (2008) Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis 21: 223-227.
10. Ng PC, Ang IL, Chiu RW, Li K, Lam HS, et al. (2010) Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 120: 2989-3000.
11. Buhimschi IA, Buhimschi CS, (2010) The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis. Clin Perinatol 37: 355-374.
12. Buhimschi IA, Christner R, Buhimschi CS, (2005) Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 112: 173-181.
13. Buhimschi CS, Buhimschi IA, Abdel-Razeq S, Rosenberg VA, Thung SF, et al. (2007) Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res 61: 318-324.
14. ACOG Committee on Practice Bulletins-Obstetrics (2007) ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 109: 1007-1019.
15. Hadlock FP, Deter RL, Harrist RB, Park SK, (1983) Computer assisted analysis of fetal age in the third trimester using multiple fetal growth parameters. J Clin Ultrasound 11: 313-316.
16. Naef RW 3rd, Allbert JR, Ross EL, Weber BM, Martin RW, et al. (1998) Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol 178: 126-130.
17. Edwards RK, Clark P, Locksmith Gregory J, Duff P, (2001) Performance characteristics of putative tests for subclinical chorioamnionitis. Infect Dis Obstet Gynecol 9: 209-214.
18. Garry D, Figueroa R, Aguero-Rosenfeld M, Martinez E, Visintainer P, et al. (1996) A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery. Am J Obstet Gynecol 175: 1336-1341.
19. Naeye RL, (1992) Disorders of the placenta, fetus and neonate: diagnosis and clinical significance. St. Louis Mosby pp. 118-247.
20. Salafia CM, Weigl C, Silberman L, (1989) The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 73: 383-389.
21. Papile LS, Burstein J, Rea Burstein, (1978) Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with weights less than 1500 grams. J Pediatr 92: 529-534.
22. The Committee for the Classification of Retinopathy of Prematurity (1984) An international classification of retinopathy of prematurity. Arch Ophthalmol 102: 1130-1134.
23. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, et al. (1991) Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 119: 630-638.
24. Bhandari A, Bhandari V, (2009) Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 123: 1562-1573.
25. Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, et al. (2009) Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG 116: 257-267.
26. Ramström M, Hagman C, Mitchell JK, Derrick PJ, Håkansson P, et al. (2005) Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 4: 410-416.
27. Shifman MA, Li Y, Colangelo CM, Stone KL, Wu TL, et al. (2007) YPED: a web-accessible database system for protein expression analysis. J Proteome Res 6: 4019-4024.
28. Kersey PJ, Duarte J, Williams A, Karavidopoulou Y, Birney E, et al. (2004) The International Protein Index: an integrated database for proteomics experiments. Proteomics 4: 1985-1988.
29. Maeda N, Smithies O, (1986) The evolution of multigene families: human haptoglobin genes. Annu Rev Genet 20: 81-108.
30. Bensi G, Raugei G, Klefenz H, Cortese R, (1985) Structure and expression of the human haptoglobin locus. EMBO J 4: 119-126.
31. Smithies O, Connell GE, Dixon GH, (1962) Chromosomal rearrangements and the evolution of haptoglobin genes. Nature 196: 232-236.
32. Nyman M, (1959) Serum haptoglobin. Methodical and clinical studies. Scand J Clin Lab Invest 11(Supp 39): 1-169.
33. Vermunt JK, Magidson J, (2002) Latent class cluster analysis.In Applied latent class analysis. Edited by Hagenaars J, McCutcheon A.Cambridge University Press pp. 89-106.
34. Buttery JP, (2002) Blood cultures in newborns and children: optimizing an everyday test. Arch Dis Child Fetal Neonatal Ed 87: F25-28.
35. Miller ME, (1977) Host defenses in the human neonate. Pediatr Clin North Am 24: 413-23.
36. Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, et al. (2008) The Alabama Preterm Birth Study: umbilical CB Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 198: e1-5.
37. Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS, (2009) Uncultivable bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 47: 38-47.
38. Gerdes JS, (2004) Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 51: 939-959.
39. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG, (2008) Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 29: 914-920.
40. Yurdakök M, (1998) Antibiotic use in neonatal sepsis. Turk J Pediatr 40: 17-33.
41. Mtitimila EI, Cooke RW, (2004) Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database Syst Rev CD004495.
42. Spitzer AR, Kirkby S, Kornhauser M, (2005) Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol 25: 265-269.
43. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, et al. (2009) NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123: 58-66.
44. Kalenic S, Francetic I, Polak J, Zele-Starcevic L, Bencic Z, (1993) Impact of ampicillin and cefuroxime on bacterial colonization and infection in patients on a neonatal intensive care unit. The Journal of Hospital Infection 23: 35-41.
45. Gabay C, Kushner I, (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454.
46. Rodwell RL, Leslie AL, Tudehope DI, (1988) Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr 112: 761-767.
47. Santana Reyes C, García-Muñoz F, Reyes D, González G, Dominguez C, et al. (2003) Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatr 92: 221-227.
48. Bhandari V, Wang C, Rinder C, Rinder H, (2008) Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 121: 129-134.
49. Benitz WE, (2010) Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol 37: 421-438.
50. He QY, Lau GK, Zhou Y, Yuen ST, Lin MC, et al. (2003) Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study. Proteomics 3: 666-674.
51. Gomme PT, Bertolini J, (2004) Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 22: 340-345.
52. Day JR, O'Hara PJ, Grant FJ, Lofton-Day C, Berkaw MN, et al. (1992) Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (β2-glycoprotein I). Int J Clin Lab Res 21: 256-263.
53. Paik YK, Chang DJ, Reardon CA, Walker MD, Taxman E, et al. (1988) Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem 263: 13340-13349.
54. Dudich E, Semenkova L, Gorbatova E, Dudich I, Khromykh L, et al. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 19: 30-40.
55. Irony-Tur-Sinai M, Grigoriadis N, Tsiantoulas D, Touloumi O, Abramsky O, et al. (2009) Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3. J Neurol Sci 279: 80-87.
56. Gitlin D, Boesman M, (1967) Sites of serum alpha-fetoprotein synthesis in the human and in the rat. J Clin Invest 46: 1010-1016.
57. Rovamo L, Nikkila EA, Taskinen MR, Raivivo KO, (1984) Postheparin plasma lipoprotein and hepatic lipases in preterm neonates. Pediatr Res 18: 1104-1107.
58. Fleischer JG, Rossignol D, Francis GA, Chan T, Lynn M, et al. (2011) Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins. Innate Immun PIMD 21382909.
59. White TC, Berny MA, Tucker EI, Urbanus RT, de Groot PG, et al. (2008) Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J Thromb Haemost 6: 995-1002.
60. Nordøy A, Killie JE, Badimon L, Fass DN, Mao SJ, et al. (1984) The effect of lipoproteins on the synthesis of prostacyclin, von Willebrand factor and apolipoproteins A-I and A-II in cultured human endothelial cells. Atherosclerosis 50: 307-323.
61. Buhimschi IA, Buhimschi CS, Weiner CP, Kimura T, Hamar BD, et al. (2005) Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form. Clin Diagn Lab Immunol 12: 837-844.
62. Quaye IK, (2008) Haptoglobin, inflammation and disease. Trans R Trop Med Hyg 102: 735-742.
63. Oh SK, Pavlotsky N, Tauber AI, (1990) Specific binding of haptoglobin to human neutrophils and its functional consequences. J Leukoc Biol 47: 142-148.
64. Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, et al. (2005) Haptoglobin dampens endotoxin induced inflammatory effects both in vitro and in vivo. Immunology 114: 263-271.
65. Baseler MW, Burrell R, (1983) Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responses. Inflammation 7: 387-400.
66. Oliviero S, Cortese R, (1989) The human haptoglobin gene promoter: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. EMBO J 8: 1145-1151.
67. Miyano A, Miyamichi T, Nakayama M, Kitajima H, Shimizu A, (1998) Differences among acute, subacute, and chronic chorioamnionitis based on levels of inflammation-associated proteins in cord blood. Pediatr Dev Pathol 1: 513-521.
68. Hatada S, Grant DJ, Maeda N, (2003) An intronic endogenous retrovirus-like sequence attenuates human haptoglobin-related gene expression in an orientation-dependent manner. Gene 319: 55-63.
69. Thomson R, Samanovic M, Raper J, (2009) Activity of trypanosome lytic factor: a novel component of innate immunity. Future Microbiol 4: 789-796.
70. Polonovski M, Jayle MF, (1938) Existence dans le plasma humain d'une sunstance activant l'action peroxydasique de l'hemoglobine. C.R. Soc. Biol 129: 457-461.
71. Rausen AR, Gerald PS, Diamond LK, (1961) Haptoglobin patterns in cord blood serums. Nature 191: 717.
72. Kanakoudi F, Drossou V, Tzimouli V, Diamanti E, Konstantinidis T, et al. (1995) Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 41: 605-608.
73. Kalayci AG Yilmazer F, Adam B, Sancak R, Küçüködüks, (2000) The importance of fibronectin, haptoglobin, ceruloplasmin and transferrin in the early diagnosis of neonatal sepsis. Turk J Med Sci 30: 151-155.
74. Speer C, Bruns A, Gahr M, (1983) Sequential determination of CRP, alpha 1-antitrypsin and haptoglobin in neonatal septicaemia. Acta Paediatr Scand 72: 679-683.
75. Salmi TT, (1973) Haptoglobin levels in the plasma of newborn infants with special reference to infections. Acta Paediatr Scand 241: 1-55.
76. Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM, (2004) New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4: 751-760.
77. Scott AN, Joseph L, Bélisle P, Behr MA, Schwartzman K, (2008) Bayesian modeling of tuberculosis clustering from DNA fingerprint data. Stat Med 27: 140-156.
78. Vergani P, Patanè L, Doria P, Borroni C, Cappellini A, et al. (2000) Risk factors for neonatal intraventricular haemorrhage in spontaneous prematurity at 32 weeks gestation or less. Placenta 21: 402-407.
79. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, et al. (2007) DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA 104: 19351-19356.
80. Hunt NH, Driussi C, Sai-Kiang L, (2001) Haptoglobin and malaria. Redox Rep 6: 389-392.
81. Langlois MR, Delanghe JR, (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600.
82. Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP, (2007) Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 191: 48-53.